nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ACHE—kidney cancer	0.355	0.55	CbGaD
Neostigmine—BCHE—kidney cancer	0.209	0.323	CbGaD
Neostigmine—ABCB1—kidney cancer	0.0817	0.127	CbGaD
Neostigmine—ABCB1—Temsirolimus—kidney cancer	0.0533	0.225	CbGbCtD
Neostigmine—ABCB1—Pazopanib—kidney cancer	0.028	0.118	CbGbCtD
Neostigmine—ABCB1—Dactinomycin—kidney cancer	0.0256	0.108	CbGbCtD
Neostigmine—ABCB1—Gemcitabine—kidney cancer	0.0202	0.0856	CbGbCtD
Neostigmine—ABCB1—Erlotinib—kidney cancer	0.02	0.0845	CbGbCtD
Neostigmine—ABCB1—Paclitaxel—kidney cancer	0.0183	0.0773	CbGbCtD
Neostigmine—ABCB1—Sorafenib—kidney cancer	0.0162	0.0687	CbGbCtD
Neostigmine—ABCB1—Vinblastine—kidney cancer	0.016	0.0678	CbGbCtD
Neostigmine—ABCB1—Vincristine—kidney cancer	0.0158	0.0667	CbGbCtD
Neostigmine—ABCB1—Sunitinib—kidney cancer	0.0132	0.0557	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—kidney cancer	0.00986	0.0417	CbGbCtD
Neostigmine—Demecarium—ACHE—kidney cancer	0.00164	0.237	CrCbGaD
Neostigmine—Pyridostigmine—ACHE—kidney cancer	0.00106	0.153	CrCbGaD
Neostigmine—Demecarium—BCHE—kidney cancer	0.000966	0.139	CrCbGaD
Neostigmine—Edrophonium—ACHE—kidney cancer	0.000863	0.124	CrCbGaD
Neostigmine—Rivastigmine—ACHE—kidney cancer	0.000802	0.116	CrCbGaD
Neostigmine—Pyridostigmine—BCHE—kidney cancer	0.000622	0.0898	CrCbGaD
Neostigmine—Edrophonium—BCHE—kidney cancer	0.000507	0.0732	CrCbGaD
Neostigmine—Rivastigmine—BCHE—kidney cancer	0.000472	0.068	CrCbGaD
Neostigmine—Nervous system disorder—Sunitinib—kidney cancer	0.000199	0.00203	CcSEcCtD
Neostigmine—Gastrointestinal pain—Everolimus—kidney cancer	0.000199	0.00202	CcSEcCtD
Neostigmine—Skin disorder—Sunitinib—kidney cancer	0.000198	0.00201	CcSEcCtD
Neostigmine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000197	0.002	CcSEcCtD
Neostigmine—Vomiting—Pazopanib—kidney cancer	0.000196	0.00199	CcSEcCtD
Neostigmine—Bradycardia—Paclitaxel—kidney cancer	0.000196	0.00199	CcSEcCtD
Neostigmine—Rash—Pazopanib—kidney cancer	0.000194	0.00198	CcSEcCtD
Neostigmine—Nausea—Temsirolimus—kidney cancer	0.000194	0.00198	CcSEcCtD
Neostigmine—Dermatitis—Pazopanib—kidney cancer	0.000194	0.00198	CcSEcCtD
Neostigmine—Bronchospasm—Capecitabine—kidney cancer	0.000194	0.00197	CcSEcCtD
Neostigmine—Agitation—Vincristine—kidney cancer	0.000194	0.00197	CcSEcCtD
Neostigmine—Abdominal pain—Vinblastine—kidney cancer	0.000193	0.00196	CcSEcCtD
Neostigmine—Headache—Pazopanib—kidney cancer	0.000193	0.00196	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000193	0.00196	CcSEcCtD
Neostigmine—Abdominal pain—Everolimus—kidney cancer	0.000192	0.00196	CcSEcCtD
Neostigmine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000192	0.00195	CcSEcCtD
Neostigmine—Sweating increased—Capecitabine—kidney cancer	0.000192	0.00195	CcSEcCtD
Neostigmine—Urinary tract disorder—Paclitaxel—kidney cancer	0.00019	0.00193	CcSEcCtD
Neostigmine—Connective tissue disorder—Paclitaxel—kidney cancer	0.000189	0.00192	CcSEcCtD
Neostigmine—Urethral disorder—Paclitaxel—kidney cancer	0.000189	0.00192	CcSEcCtD
Neostigmine—Dyspnoea—Sorafenib—kidney cancer	0.000188	0.00192	CcSEcCtD
Neostigmine—Abdominal pain—Erlotinib—kidney cancer	0.000186	0.00189	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000185	0.00188	CcSEcCtD
Neostigmine—Coma—Doxorubicin—kidney cancer	0.000185	0.00188	CcSEcCtD
Neostigmine—Insomnia—Sunitinib—kidney cancer	0.000184	0.00187	CcSEcCtD
Neostigmine—Nausea—Pazopanib—kidney cancer	0.000183	0.00186	CcSEcCtD
Neostigmine—Convulsion—Vincristine—kidney cancer	0.000183	0.00186	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000182	0.00186	CcSEcCtD
Neostigmine—Dyspnoea—Sunitinib—kidney cancer	0.000181	0.00184	CcSEcCtD
Neostigmine—Hypersensitivity—Vinblastine—kidney cancer	0.00018	0.00183	CcSEcCtD
Neostigmine—Hypersensitivity—Everolimus—kidney cancer	0.000179	0.00182	CcSEcCtD
Neostigmine—Flushing—Paclitaxel—kidney cancer	0.000178	0.00181	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000176	0.00179	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000175	0.00178	CcSEcCtD
Neostigmine—Asthenia—Vinblastine—kidney cancer	0.000175	0.00178	CcSEcCtD
Neostigmine—Asthenia—Everolimus—kidney cancer	0.000175	0.00178	CcSEcCtD
Neostigmine—Mediastinal disorder—Paclitaxel—kidney cancer	0.000173	0.00176	CcSEcCtD
Neostigmine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000173	0.00176	CcSEcCtD
Neostigmine—Pruritus—Everolimus—kidney cancer	0.000172	0.00175	CcSEcCtD
Neostigmine—Anaphylactic shock—Vincristine—kidney cancer	0.000172	0.00175	CcSEcCtD
Neostigmine—Arrhythmia—Paclitaxel—kidney cancer	0.000172	0.00175	CcSEcCtD
Neostigmine—Arthralgia—Gemcitabine—kidney cancer	0.00017	0.00173	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000169	0.00172	CcSEcCtD
Neostigmine—Nervous system disorder—Vincristine—kidney cancer	0.000169	0.00172	CcSEcCtD
Neostigmine—Asthenia—Erlotinib—kidney cancer	0.000169	0.00171	CcSEcCtD
Neostigmine—Mental disorder—Paclitaxel—kidney cancer	0.000168	0.00171	CcSEcCtD
Neostigmine—Urticaria—Sorafenib—kidney cancer	0.000168	0.00171	CcSEcCtD
Neostigmine—Diarrhoea—Vinblastine—kidney cancer	0.000167	0.0017	CcSEcCtD
Neostigmine—Abdominal pain—Sorafenib—kidney cancer	0.000167	0.0017	CcSEcCtD
Neostigmine—Diarrhoea—Everolimus—kidney cancer	0.000167	0.00169	CcSEcCtD
Neostigmine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000166	0.00169	CcSEcCtD
Neostigmine—Hyperhidrosis—Vincristine—kidney cancer	0.000166	0.00169	CcSEcCtD
Neostigmine—Pruritus—Erlotinib—kidney cancer	0.000166	0.00169	CcSEcCtD
Neostigmine—Flatulence—Paclitaxel—kidney cancer	0.000165	0.00168	CcSEcCtD
Neostigmine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000163	0.00166	CcSEcCtD
Neostigmine—Dizziness—Vinblastine—kidney cancer	0.000162	0.00164	CcSEcCtD
Neostigmine—Dizziness—Everolimus—kidney cancer	0.000161	0.00164	CcSEcCtD
Neostigmine—Muscle spasms—Paclitaxel—kidney cancer	0.000161	0.00164	CcSEcCtD
Neostigmine—Abdominal pain—Sunitinib—kidney cancer	0.000161	0.00163	CcSEcCtD
Neostigmine—Diarrhoea—Erlotinib—kidney cancer	0.000161	0.00163	CcSEcCtD
Neostigmine—Hypotension—Vincristine—kidney cancer	0.000161	0.00163	CcSEcCtD
Neostigmine—Bradycardia—Capecitabine—kidney cancer	0.000161	0.00163	CcSEcCtD
Neostigmine—Nervous system disorder—Gemcitabine—kidney cancer	0.00016	0.00163	CcSEcCtD
Neostigmine—Skin disorder—Gemcitabine—kidney cancer	0.000159	0.00161	CcSEcCtD
Neostigmine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000158	0.0016	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000157	0.0016	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000157	0.00159	CcSEcCtD
Neostigmine—Urinary tract disorder—Capecitabine—kidney cancer	0.000156	0.00158	CcSEcCtD
Neostigmine—Hypersensitivity—Sorafenib—kidney cancer	0.000156	0.00158	CcSEcCtD
Neostigmine—Insomnia—Vincristine—kidney cancer	0.000156	0.00158	CcSEcCtD
Neostigmine—Vomiting—Vinblastine—kidney cancer	0.000155	0.00158	CcSEcCtD
Neostigmine—Dizziness—Erlotinib—kidney cancer	0.000155	0.00158	CcSEcCtD
Neostigmine—Connective tissue disorder—Capecitabine—kidney cancer	0.000155	0.00158	CcSEcCtD
Neostigmine—Vomiting—Everolimus—kidney cancer	0.000155	0.00157	CcSEcCtD
Neostigmine—Urethral disorder—Capecitabine—kidney cancer	0.000155	0.00157	CcSEcCtD
Neostigmine—Agitation—Paclitaxel—kidney cancer	0.000154	0.00156	CcSEcCtD
Neostigmine—Rash—Everolimus—kidney cancer	0.000154	0.00156	CcSEcCtD
Neostigmine—Dermatitis—Everolimus—kidney cancer	0.000153	0.00156	CcSEcCtD
Neostigmine—Headache—Vinblastine—kidney cancer	0.000153	0.00156	CcSEcCtD
Neostigmine—Headache—Everolimus—kidney cancer	0.000153	0.00155	CcSEcCtD
Neostigmine—Hypotension—Gemcitabine—kidney cancer	0.000152	0.00155	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—kidney cancer	0.000152	0.00155	CcSEcCtD
Neostigmine—Asthenia—Sorafenib—kidney cancer	0.000152	0.00154	CcSEcCtD
Neostigmine—Syncope—Paclitaxel—kidney cancer	0.00015	0.00153	CcSEcCtD
Neostigmine—Hypersensitivity—Sunitinib—kidney cancer	0.00015	0.00152	CcSEcCtD
Neostigmine—Pruritus—Sorafenib—kidney cancer	0.00015	0.00152	CcSEcCtD
Neostigmine—Vomiting—Erlotinib—kidney cancer	0.000149	0.00152	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000149	0.00151	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000149	0.00151	CcSEcCtD
Neostigmine—Rash—Erlotinib—kidney cancer	0.000148	0.00151	CcSEcCtD
Neostigmine—Dermatitis—Erlotinib—kidney cancer	0.000148	0.0015	CcSEcCtD
Neostigmine—Insomnia—Gemcitabine—kidney cancer	0.000148	0.0015	CcSEcCtD
Neostigmine—Headache—Erlotinib—kidney cancer	0.000147	0.0015	CcSEcCtD
Neostigmine—Loss of consciousness—Paclitaxel—kidney cancer	0.000147	0.0015	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—kidney cancer	0.000147	0.0015	CcSEcCtD
Neostigmine—Flushing—Capecitabine—kidney cancer	0.000146	0.00149	CcSEcCtD
Neostigmine—Asthenia—Sunitinib—kidney cancer	0.000146	0.00148	CcSEcCtD
Neostigmine—Dyspnoea—Gemcitabine—kidney cancer	0.000145	0.00148	CcSEcCtD
Neostigmine—Nausea—Vinblastine—kidney cancer	0.000145	0.00148	CcSEcCtD
Neostigmine—Somnolence—Gemcitabine—kidney cancer	0.000145	0.00147	CcSEcCtD
Neostigmine—Convulsion—Paclitaxel—kidney cancer	0.000145	0.00147	CcSEcCtD
Neostigmine—Nausea—Everolimus—kidney cancer	0.000145	0.00147	CcSEcCtD
Neostigmine—Diarrhoea—Sorafenib—kidney cancer	0.000145	0.00147	CcSEcCtD
Neostigmine—Pruritus—Sunitinib—kidney cancer	0.000144	0.00146	CcSEcCtD
Neostigmine—Arthralgia—Paclitaxel—kidney cancer	0.000143	0.00145	CcSEcCtD
Neostigmine—Mediastinal disorder—Capecitabine—kidney cancer	0.000142	0.00145	CcSEcCtD
Neostigmine—Hypersensitivity—Dactinomycin—kidney cancer	0.000142	0.00144	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000142	0.00144	CcSEcCtD
Neostigmine—Arrhythmia—Capecitabine—kidney cancer	0.000141	0.00143	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000141	0.00143	CcSEcCtD
Neostigmine—Gastrointestinal pain—Vincristine—kidney cancer	0.000141	0.00143	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—kidney cancer	0.00014	0.00142	CcSEcCtD
Neostigmine—Dizziness—Sorafenib—kidney cancer	0.00014	0.00142	CcSEcCtD
Neostigmine—Nausea—Erlotinib—kidney cancer	0.00014	0.00142	CcSEcCtD
Neostigmine—Dry mouth—Paclitaxel—kidney cancer	0.000139	0.00142	CcSEcCtD
Neostigmine—Diarrhoea—Sunitinib—kidney cancer	0.000139	0.00141	CcSEcCtD
Neostigmine—Mental disorder—Capecitabine—kidney cancer	0.000138	0.00141	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—kidney cancer	0.000138	0.0014	CcSEcCtD
Neostigmine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000137	0.00139	CcSEcCtD
Neostigmine—Abdominal pain—Vincristine—kidney cancer	0.000136	0.00138	CcSEcCtD
Neostigmine—Flatulence—Capecitabine—kidney cancer	0.000135	0.00138	CcSEcCtD
Neostigmine—Dizziness—Sunitinib—kidney cancer	0.000134	0.00137	CcSEcCtD
Neostigmine—Shock—Paclitaxel—kidney cancer	0.000134	0.00137	CcSEcCtD
Neostigmine—Vomiting—Sorafenib—kidney cancer	0.000134	0.00137	CcSEcCtD
Neostigmine—Nervous system disorder—Paclitaxel—kidney cancer	0.000134	0.00136	CcSEcCtD
Neostigmine—Tachycardia—Paclitaxel—kidney cancer	0.000133	0.00136	CcSEcCtD
Neostigmine—Rash—Sorafenib—kidney cancer	0.000133	0.00135	CcSEcCtD
Neostigmine—Dermatitis—Sorafenib—kidney cancer	0.000133	0.00135	CcSEcCtD
Neostigmine—Skin disorder—Paclitaxel—kidney cancer	0.000133	0.00135	CcSEcCtD
Neostigmine—Headache—Sorafenib—kidney cancer	0.000132	0.00135	CcSEcCtD
Neostigmine—Muscle spasms—Capecitabine—kidney cancer	0.000132	0.00134	CcSEcCtD
Neostigmine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000132	0.00134	CcSEcCtD
Neostigmine—Diarrhoea—Dactinomycin—kidney cancer	0.000132	0.00134	CcSEcCtD
Neostigmine—Vomiting—Sunitinib—kidney cancer	0.000129	0.00131	CcSEcCtD
Neostigmine—Rash—Sunitinib—kidney cancer	0.000128	0.0013	CcSEcCtD
Neostigmine—Dermatitis—Sunitinib—kidney cancer	0.000128	0.0013	CcSEcCtD
Neostigmine—Hypotension—Paclitaxel—kidney cancer	0.000128	0.0013	CcSEcCtD
Neostigmine—Headache—Sunitinib—kidney cancer	0.000127	0.0013	CcSEcCtD
Neostigmine—Hypersensitivity—Vincristine—kidney cancer	0.000127	0.00129	CcSEcCtD
Neostigmine—Nausea—Sorafenib—kidney cancer	0.000126	0.00128	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000124	0.00127	CcSEcCtD
Neostigmine—Insomnia—Paclitaxel—kidney cancer	0.000124	0.00126	CcSEcCtD
Neostigmine—Asthenia—Vincristine—kidney cancer	0.000123	0.00125	CcSEcCtD
Neostigmine—Syncope—Capecitabine—kidney cancer	0.000123	0.00125	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—kidney cancer	0.000122	0.00124	CcSEcCtD
Neostigmine—Dyspnoea—Paclitaxel—kidney cancer	0.000122	0.00124	CcSEcCtD
Neostigmine—Somnolence—Paclitaxel—kidney cancer	0.000121	0.00123	CcSEcCtD
Neostigmine—Rash—Dactinomycin—kidney cancer	0.000121	0.00123	CcSEcCtD
Neostigmine—Nausea—Sunitinib—kidney cancer	0.000121	0.00123	CcSEcCtD
Neostigmine—Loss of consciousness—Capecitabine—kidney cancer	0.000121	0.00123	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000118	0.0012	CcSEcCtD
Neostigmine—Diarrhoea—Vincristine—kidney cancer	0.000118	0.0012	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—kidney cancer	0.000117	0.00119	CcSEcCtD
Neostigmine—Asthenia—Gemcitabine—kidney cancer	0.000117	0.00119	CcSEcCtD
Neostigmine—Arthralgia—Capecitabine—kidney cancer	0.000117	0.00119	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000116	0.00118	CcSEcCtD
Neostigmine—Pruritus—Gemcitabine—kidney cancer	0.000115	0.00117	CcSEcCtD
Neostigmine—Dry mouth—Capecitabine—kidney cancer	0.000114	0.00116	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—kidney cancer	0.000114	0.00116	CcSEcCtD
Neostigmine—Dizziness—Vincristine—kidney cancer	0.000114	0.00116	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—kidney cancer	0.000113	0.00115	CcSEcCtD
Neostigmine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000112	0.00114	CcSEcCtD
Neostigmine—Diarrhoea—Gemcitabine—kidney cancer	0.000112	0.00114	CcSEcCtD
Neostigmine—Shock—Capecitabine—kidney cancer	0.00011	0.00112	CcSEcCtD
Neostigmine—Nervous system disorder—Capecitabine—kidney cancer	0.00011	0.00112	CcSEcCtD
Neostigmine—Tachycardia—Capecitabine—kidney cancer	0.000109	0.00111	CcSEcCtD
Neostigmine—Vomiting—Vincristine—kidney cancer	0.000109	0.00111	CcSEcCtD
Neostigmine—Skin disorder—Capecitabine—kidney cancer	0.000109	0.00111	CcSEcCtD
Neostigmine—Urticaria—Paclitaxel—kidney cancer	0.000109	0.0011	CcSEcCtD
Neostigmine—Rash—Vincristine—kidney cancer	0.000108	0.0011	CcSEcCtD
Neostigmine—Hyperhidrosis—Capecitabine—kidney cancer	0.000108	0.0011	CcSEcCtD
Neostigmine—Dermatitis—Vincristine—kidney cancer	0.000108	0.0011	CcSEcCtD
Neostigmine—Abdominal pain—Paclitaxel—kidney cancer	0.000108	0.0011	CcSEcCtD
Neostigmine—Headache—Vincristine—kidney cancer	0.000108	0.0011	CcSEcCtD
Neostigmine—Hypotension—Capecitabine—kidney cancer	0.000105	0.00107	CcSEcCtD
Neostigmine—Vomiting—Gemcitabine—kidney cancer	0.000104	0.00105	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—kidney cancer	0.000104	0.00105	CcSEcCtD
Neostigmine—Rash—Gemcitabine—kidney cancer	0.000103	0.00105	CcSEcCtD
Neostigmine—Dermatitis—Gemcitabine—kidney cancer	0.000103	0.00105	CcSEcCtD
Neostigmine—Headache—Gemcitabine—kidney cancer	0.000102	0.00104	CcSEcCtD
Neostigmine—Nausea—Vincristine—kidney cancer	0.000102	0.00104	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000102	0.00104	CcSEcCtD
Neostigmine—Insomnia—Capecitabine—kidney cancer	0.000101	0.00103	CcSEcCtD
Neostigmine—Hypersensitivity—Paclitaxel—kidney cancer	0.000101	0.00102	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—kidney cancer	0.0001	0.00102	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—kidney cancer	0.0001	0.00102	CcSEcCtD
Neostigmine—Dyspnoea—Capecitabine—kidney cancer	0.0001	0.00102	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—kidney cancer	9.97e-05	0.00101	CcSEcCtD
Neostigmine—Asthenia—Paclitaxel—kidney cancer	9.8e-05	0.000997	CcSEcCtD
Neostigmine—Nausea—Gemcitabine—kidney cancer	9.69e-05	0.000985	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Capecitabine—kidney cancer	9.68e-05	0.000984	CcSEcCtD
Neostigmine—Pruritus—Paclitaxel—kidney cancer	9.67e-05	0.000983	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—kidney cancer	9.44e-05	0.00096	CcSEcCtD
Neostigmine—Diarrhoea—Paclitaxel—kidney cancer	9.35e-05	0.00095	CcSEcCtD
Neostigmine—Gastrointestinal pain—Capecitabine—kidney cancer	9.17e-05	0.000932	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—kidney cancer	9.17e-05	0.000932	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—kidney cancer	9.09e-05	0.000924	CcSEcCtD
Neostigmine—Dizziness—Paclitaxel—kidney cancer	9.04e-05	0.000919	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—kidney cancer	8.91e-05	0.000906	CcSEcCtD
Neostigmine—Urticaria—Capecitabine—kidney cancer	8.91e-05	0.000906	CcSEcCtD
Neostigmine—Abdominal pain—Capecitabine—kidney cancer	8.86e-05	0.000901	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—kidney cancer	8.73e-05	0.000887	CcSEcCtD
Neostigmine—Vomiting—Paclitaxel—kidney cancer	8.69e-05	0.000883	CcSEcCtD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	8.66e-05	0.00668	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	8.65e-05	0.00668	CbGpPWpGaD
Neostigmine—Rash—Paclitaxel—kidney cancer	8.61e-05	0.000876	CcSEcCtD
Neostigmine—Dermatitis—Paclitaxel—kidney cancer	8.61e-05	0.000875	CcSEcCtD
Neostigmine—Headache—Paclitaxel—kidney cancer	8.56e-05	0.00087	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—kidney cancer	8.51e-05	0.000866	CcSEcCtD
Neostigmine—ACHE—Phospholipid metabolism—BCHE—kidney cancer	8.5e-05	0.00656	CbGpPWpGaD
Neostigmine—Hypersensitivity—Capecitabine—kidney cancer	8.26e-05	0.00084	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—kidney cancer	8.14e-05	0.000827	CcSEcCtD
Neostigmine—Nausea—Paclitaxel—kidney cancer	8.12e-05	0.000825	CcSEcCtD
Neostigmine—Asthenia—Capecitabine—kidney cancer	8.04e-05	0.000818	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—kidney cancer	7.94e-05	0.000807	CcSEcCtD
Neostigmine—Pruritus—Capecitabine—kidney cancer	7.93e-05	0.000807	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—kidney cancer	7.78e-05	0.000791	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—kidney cancer	7.67e-05	0.00078	CcSEcCtD
Neostigmine—Diarrhoea—Capecitabine—kidney cancer	7.67e-05	0.00078	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—kidney cancer	7.54e-05	0.000767	CcSEcCtD
Neostigmine—ACHE—Neuronal System—KCNMA1—kidney cancer	7.51e-05	0.0058	CbGpPWpGaD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.49e-05	0.000761	CcSEcCtD
Neostigmine—Dizziness—Capecitabine—kidney cancer	7.41e-05	0.000754	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—kidney cancer	7.37e-05	0.00075	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—kidney cancer	7.23e-05	0.000735	CcSEcCtD
Neostigmine—ACHE—Metabolism of proteins—EIF5B—kidney cancer	7.17e-05	0.00553	CbGpPWpGaD
Neostigmine—Vomiting—Capecitabine—kidney cancer	7.13e-05	0.000725	CcSEcCtD
Neostigmine—Shock—Doxorubicin—kidney cancer	7.11e-05	0.000723	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—kidney cancer	7.09e-05	0.000721	CcSEcCtD
Neostigmine—Rash—Capecitabine—kidney cancer	7.07e-05	0.000719	CcSEcCtD
Neostigmine—Dermatitis—Capecitabine—kidney cancer	7.06e-05	0.000718	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—kidney cancer	7.05e-05	0.000717	CcSEcCtD
Neostigmine—Headache—Capecitabine—kidney cancer	7.02e-05	0.000714	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—kidney cancer	7.02e-05	0.000714	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—kidney cancer	6.99e-05	0.00071	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	6.92e-05	0.00534	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.77e-05	0.00522	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL13—kidney cancer	6.76e-05	0.00522	CbGpPWpGaD
Neostigmine—Hypotension—Doxorubicin—kidney cancer	6.75e-05	0.000687	CcSEcCtD
Neostigmine—BCHE—Neuronal System—KCNMA1—kidney cancer	6.7e-05	0.00517	CbGpPWpGaD
Neostigmine—Nausea—Capecitabine—kidney cancer	6.66e-05	0.000677	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.58e-05	0.000669	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—kidney cancer	6.54e-05	0.000665	CcSEcCtD
Neostigmine—ACHE—Peptide hormone metabolism—POMC—kidney cancer	6.48e-05	0.005	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—ACHE—kidney cancer	6.47e-05	0.00499	CbGpPWpGaD
Neostigmine—Dyspnoea—Doxorubicin—kidney cancer	6.44e-05	0.000655	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—kidney cancer	6.43e-05	0.000653	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—EIF5B—kidney cancer	6.4e-05	0.00494	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CUL7—kidney cancer	6.39e-05	0.00493	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	6.37e-05	0.00492	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—BCHE—kidney cancer	6.32e-05	0.00488	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—CCND1—kidney cancer	6.25e-05	0.00482	CbGpPWpGaD
Neostigmine—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.24e-05	0.000634	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—JUN—kidney cancer	6.24e-05	0.00481	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.21e-05	0.00479	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.21e-05	0.00479	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—HSPA9—kidney cancer	6.1e-05	0.00471	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.04e-05	0.00466	CbGpPWpGaD
Neostigmine—Gastrointestinal pain—Doxorubicin—kidney cancer	5.91e-05	0.000601	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	5.81e-05	0.00448	CbGpPWpGaD
Neostigmine—BCHE—Peptide hormone metabolism—POMC—kidney cancer	5.78e-05	0.00446	CbGpPWpGaD
Neostigmine—Urticaria—Doxorubicin—kidney cancer	5.74e-05	0.000584	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—kidney cancer	5.71e-05	0.000581	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—CUL7—kidney cancer	5.7e-05	0.0044	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPA9—kidney cancer	5.44e-05	0.0042	CbGpPWpGaD
Neostigmine—Hypersensitivity—Doxorubicin—kidney cancer	5.33e-05	0.000541	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—kidney cancer	5.19e-05	0.000527	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—MAPK3—kidney cancer	5.15e-05	0.00398	CbGpPWpGaD
Neostigmine—Pruritus—Doxorubicin—kidney cancer	5.11e-05	0.00052	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.1e-05	0.00393	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.05e-05	0.0039	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MUC4—kidney cancer	4.97e-05	0.00384	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—ACHE—kidney cancer	4.96e-05	0.00383	CbGpPWpGaD
Neostigmine—Diarrhoea—Doxorubicin—kidney cancer	4.95e-05	0.000503	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	4.94e-05	0.00381	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—MAPK1—kidney cancer	4.9e-05	0.00378	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BCHE—kidney cancer	4.84e-05	0.00374	CbGpPWpGaD
Neostigmine—Dizziness—Doxorubicin—kidney cancer	4.78e-05	0.000486	CcSEcCtD
Neostigmine—ACHE—Metabolism of proteins—ST3GAL2—kidney cancer	4.73e-05	0.00365	CbGpPWpGaD
Neostigmine—ACHE—Peptide hormone metabolism—CTNNB1—kidney cancer	4.62e-05	0.00357	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—EEF2—kidney cancer	4.62e-05	0.00357	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	4.6e-05	0.00355	CbGpPWpGaD
Neostigmine—Vomiting—Doxorubicin—kidney cancer	4.6e-05	0.000467	CcSEcCtD
Neostigmine—Rash—Doxorubicin—kidney cancer	4.56e-05	0.000463	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—kidney cancer	4.55e-05	0.000463	CcSEcCtD
Neostigmine—Headache—Doxorubicin—kidney cancer	4.53e-05	0.00046	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—MUC4—kidney cancer	4.43e-05	0.00342	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ACY1—kidney cancer	4.35e-05	0.00335	CbGpPWpGaD
Neostigmine—Nausea—Doxorubicin—kidney cancer	4.29e-05	0.000436	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—ST3GAL2—kidney cancer	4.22e-05	0.00326	CbGpPWpGaD
Neostigmine—BCHE—Peptide hormone metabolism—CTNNB1—kidney cancer	4.12e-05	0.00318	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—EEF2—kidney cancer	4.12e-05	0.00318	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	4.12e-05	0.00318	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	3.97e-05	0.00307	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	3.97e-05	0.00307	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ACY1—kidney cancer	3.88e-05	0.00299	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	3.77e-05	0.00291	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.71e-05	0.00286	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PDHB—kidney cancer	3.7e-05	0.00285	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	3.7e-05	0.00285	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.56e-05	0.00275	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MME—kidney cancer	3.54e-05	0.00273	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CCBL1—kidney cancer	3.48e-05	0.00268	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	3.31e-05	0.00255	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.31e-05	0.00255	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PDHB—kidney cancer	3.3e-05	0.00254	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—RPL14—kidney cancer	3.29e-05	0.00254	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—HSPD1—kidney cancer	3.29e-05	0.00254	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	3.28e-05	0.00253	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—BRAF—kidney cancer	3.23e-05	0.00249	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MME—kidney cancer	3.16e-05	0.00244	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CCBL1—kidney cancer	3.1e-05	0.00239	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PTEN—kidney cancer	3.06e-05	0.00236	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GLIPR1—kidney cancer	3.01e-05	0.00233	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPAT—kidney cancer	3.01e-05	0.00233	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	3.01e-05	0.00232	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.98e-05	0.0023	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.95e-05	0.00227	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPL14—kidney cancer	2.94e-05	0.00227	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPD1—kidney cancer	2.94e-05	0.00227	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	2.88e-05	0.00222	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.8e-05	0.00216	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FH—kidney cancer	2.8e-05	0.00216	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APRT—kidney cancer	2.8e-05	0.00216	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.79e-05	0.00216	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.76e-05	0.00213	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.74e-05	0.00211	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PTEN—kidney cancer	2.73e-05	0.0021	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.7e-05	0.00209	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	2.7e-05	0.00209	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	2.7e-05	0.00209	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.69e-05	0.00208	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPAT—kidney cancer	2.69e-05	0.00207	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GLIPR1—kidney cancer	2.69e-05	0.00207	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.68e-05	0.00207	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.65e-05	0.00205	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GPC3—kidney cancer	2.63e-05	0.00203	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.63e-05	0.00203	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—PAX6—kidney cancer	2.58e-05	0.00199	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTSD—kidney cancer	2.57e-05	0.00198	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA2—kidney cancer	2.56e-05	0.00198	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.56e-05	0.00198	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.53e-05	0.00195	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	2.53e-05	0.00195	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FH—kidney cancer	2.5e-05	0.00193	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APRT—kidney cancer	2.5e-05	0.00193	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALAD—kidney cancer	2.5e-05	0.00193	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	2.48e-05	0.00192	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BRAF—kidney cancer	2.47e-05	0.00191	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.44e-05	0.00188	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ST3GAL2—kidney cancer	2.44e-05	0.00188	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.44e-05	0.00188	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ACHE—kidney cancer	2.42e-05	0.00187	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.42e-05	0.00187	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.4e-05	0.00185	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.39e-05	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDH1A1—kidney cancer	2.38e-05	0.00184	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—BCHE—kidney cancer	2.37e-05	0.00183	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.36e-05	0.00182	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GPC3—kidney cancer	2.35e-05	0.00181	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—PAX6—kidney cancer	2.31e-05	0.00178	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTSD—kidney cancer	2.29e-05	0.00177	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA2—kidney cancer	2.29e-05	0.00176	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A3—kidney cancer	2.28e-05	0.00176	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PGK1—kidney cancer	2.28e-05	0.00176	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LDHB—kidney cancer	2.24e-05	0.00173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALAD—kidney cancer	2.23e-05	0.00172	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	2.22e-05	0.00171	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—kidney cancer	2.21e-05	0.00171	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—kidney cancer	2.2e-05	0.0017	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	2.2e-05	0.0017	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ST3GAL2—kidney cancer	2.17e-05	0.00168	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.17e-05	0.00167	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.16e-05	0.00166	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.13e-05	0.00164	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDH1A1—kidney cancer	2.12e-05	0.00164	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.12e-05	0.00164	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.12e-05	0.00164	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.12e-05	0.00164	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—RAF1—kidney cancer	2.06e-05	0.00159	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A3—kidney cancer	2.04e-05	0.00157	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PGK1—kidney cancer	2.04e-05	0.00157	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.01e-05	0.00155	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LDHB—kidney cancer	2e-05	0.00154	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.96e-05	0.00151	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA9—kidney cancer	1.94e-05	0.0015	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	1.92e-05	0.00148	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.92e-05	0.00148	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.9e-05	0.00146	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACY1—kidney cancer	1.89e-05	0.00146	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.88e-05	0.00145	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.85e-05	0.00143	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—RAF1—kidney cancer	1.84e-05	0.00142	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF2—kidney cancer	1.83e-05	0.00141	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.81e-05	0.0014	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA9—kidney cancer	1.73e-05	0.00134	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.69e-05	0.00131	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.66e-05	0.00128	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CRABP1—kidney cancer	1.65e-05	0.00127	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.65e-05	0.00127	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF2—kidney cancer	1.63e-05	0.00126	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PDHB—kidney cancer	1.61e-05	0.00124	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.61e-05	0.00124	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.55e-05	0.0012	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ITPR2—kidney cancer	1.53e-05	0.00118	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CCBL1—kidney cancer	1.51e-05	0.00117	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CRABP1—kidney cancer	1.47e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MAPK1—kidney cancer	1.42e-05	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.41e-05	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—kidney cancer	1.4e-05	0.00108	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ITPR2—kidney cancer	1.37e-05	0.00106	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SCARB1—kidney cancer	1.32e-05	0.00102	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS1—kidney cancer	1.31e-05	0.00101	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPAT—kidney cancer	1.31e-05	0.00101	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GLIPR1—kidney cancer	1.31e-05	0.00101	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSMD7—kidney cancer	1.29e-05	0.000993	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MAPK1—kidney cancer	1.26e-05	0.000974	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.26e-05	0.000974	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ACHE—kidney cancer	1.25e-05	0.000964	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—kidney cancer	1.25e-05	0.000964	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—POMC—kidney cancer	1.22e-05	0.000944	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BCHE—kidney cancer	1.22e-05	0.000941	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FH—kidney cancer	1.22e-05	0.000941	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APRT—kidney cancer	1.22e-05	0.000941	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.22e-05	0.000938	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A5—kidney cancer	1.2e-05	0.000929	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.2e-05	0.000928	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SCARB1—kidney cancer	1.18e-05	0.000912	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.18e-05	0.000908	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS1—kidney cancer	1.17e-05	0.000903	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A1—kidney cancer	1.16e-05	0.000898	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSMD7—kidney cancer	1.15e-05	0.000886	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPC3—kidney cancer	1.15e-05	0.000885	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.13e-05	0.000871	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.12e-05	0.000864	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA2—kidney cancer	1.12e-05	0.000861	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.11e-05	0.00086	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—POMC—kidney cancer	1.09e-05	0.000842	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALAD—kidney cancer	1.09e-05	0.000839	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.08e-05	0.000834	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A5—kidney cancer	1.07e-05	0.000829	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.06e-05	0.00082	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.06e-05	0.000819	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.06e-05	0.000819	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.05e-05	0.000812	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000801	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.04e-05	0.0008	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.03e-05	0.000792	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.01e-05	0.000777	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PGK1—kidney cancer	9.94e-06	0.000767	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A3—kidney cancer	9.94e-06	0.000767	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.84e-06	0.00076	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LDHB—kidney cancer	9.75e-06	0.000752	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—kidney cancer	9.7e-06	0.000749	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.27e-06	0.000715	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—kidney cancer	9.18e-06	0.000709	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—kidney cancer	8.92e-06	0.000688	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.78e-06	0.000678	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.77e-06	0.000676	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	8.73e-06	0.000673	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—kidney cancer	8.66e-06	0.000668	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.53e-06	0.000658	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A1—kidney cancer	8.45e-06	0.000652	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA9—kidney cancer	8.45e-06	0.000652	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.34e-06	0.000644	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—kidney cancer	8.19e-06	0.000632	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—kidney cancer	7.95e-06	0.000614	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.88e-06	0.000608	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	7.78e-06	0.000601	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A1—kidney cancer	7.54e-06	0.000582	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.24e-06	0.000559	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CRABP1—kidney cancer	7.19e-06	0.000555	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7e-06	0.00054	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.94e-06	0.000536	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ITPR2—kidney cancer	6.68e-06	0.000516	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—POMC—kidney cancer	6.3e-06	0.000486	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.19e-06	0.000478	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—kidney cancer	6.09e-06	0.00047	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACHE—kidney cancer	6.09e-06	0.00047	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SCARB1—kidney cancer	5.77e-06	0.000445	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS1—kidney cancer	5.71e-06	0.000441	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—POMC—kidney cancer	5.62e-06	0.000434	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSMD7—kidney cancer	5.6e-06	0.000432	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BCHE—kidney cancer	5.31e-06	0.00041	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A5—kidney cancer	5.24e-06	0.000405	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A1—kidney cancer	5.06e-06	0.000391	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—kidney cancer	5.03e-06	0.000388	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.83e-06	0.000373	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—kidney cancer	4.48e-06	0.000346	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—kidney cancer	4.38e-06	0.000338	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—kidney cancer	4.22e-06	0.000326	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—kidney cancer	3.91e-06	0.000302	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—kidney cancer	3.88e-06	0.000299	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.68e-06	0.000284	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—kidney cancer	3.09e-06	0.000239	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—kidney cancer	2.76e-06	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—POMC—kidney cancer	2.74e-06	0.000212	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—kidney cancer	2.19e-06	0.000169	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—kidney cancer	1.91e-06	0.000147	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.35e-06	0.000104	CbGpPWpGaD
